TNIP2
TNFAIP3-interacting protein 2 is a protein that in humans is encoded by the TNIP2 gene.[1][2][3]
References
- ↑ Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R (Aug 2001). “Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2”. J Biol Chem. 276 (32): 30216–23. doi:10.1074/jbc.M100048200. PMID 11390377.
- ↑ Tadros A, Hughes DP, Dunmore BJ, Brindle NP (Dec 2003). “ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1”. Blood. 102 (13): 4407–9. doi:10.1182/blood-2003-05-1602. PMID 12933576.
- ↑ “Entrez Gene: TNIP2 TNFAIP3 interacting protein 2”.
Further reading
- Heyninck K, De Valck D, Vanden Berghe W, et al. (1999). “The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN”. J. Cell Biol. 145 (7): 1471–82. doi:10.1083/jcb.145.7.1471. hdl:1854/LU-113881. PMC 2133159. PMID 10385526.
- Klinkenberg M, Van Huffel S, Heyninck K, Beyaert R (2001). “Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions”. FEBS Lett. 498 (1): 93–7. doi:10.1016/S0014-5793(01)02504-2. PMID 11389905.
- Wu WS, Xu ZX, Chang KS (2002). “The promyelocytic leukemia protein represses A20-mediated transcription”. J. Biol. Chem. 277 (35): 31734–9. doi:10.1074/jbc.M201648200. PMID 12080044.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Liu WK, Chien CY, Chou CK, Su JY (2003). “An LKB1-interacting protein negatively regulates TNFalpha-induced NF-kappaB activation”. J. Biomed. Sci. 10 (2): 242–52. doi:10.1159/000068708. PMID 12595760.
- Hughes DP, Marron MB, Brindle NP (2003). “The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2”. Circ. Res. 92 (6): 630–6. doi:10.1161/01.RES.0000063422.38690.DC. PMID 12609966.
- Chien CY, Liu WK, Chou CK, Su JY (2003). “The A20-binding protein ABIN-2 exerts unexpected function in mediating transcriptional coactivation”. FEBS Lett. 543 (1–3): 55–60. doi:10.1016/S0014-5793(03)00401-0. PMID 12753905.
- Liu WK, Yen PF, Chien CY, et al. (2004). “The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis”. Biochem. J. 378 (Pt 3): 867–76. doi:10.1042/BJ20031736. PMC 1224013. PMID 14653779.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Bouwmeester T, Bauch A, Ruffner H, et al. (2004). “A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway”. Nat. Cell Biol. 6 (2): 97–105. doi:10.1038/ncb1086. PMID 14743216.
- Lang V, Symons A, Watton SJ, et al. (2004). “ABIN-2 Forms a Ternary Complex with TPL-2 and NF-κB1 p105 and Is Essential for TPL-2 Protein Stability”. Mol. Cell. Biol. 24 (12): 5235–48. doi:10.1128/MCB.24.12.5235-5248.2004. PMC 419892. PMID 15169888.
- Li CC, Chou CK, Wang MH, Tsai TF (2006). “Overexpression of ABIN-2, a negative regulator of NF-kappaB, delays liver regeneration in the ABIN-2 transgenic mice”. Biochem. Biophys. Res. Commun. 342 (1): 300–9. doi:10.1016/j.bbrc.2006.01.114. PMID 16480954.
- Greenberg H, Ye X, Wilson D, et al. (2006). “Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo”. Biochem. Biophys. Res. Commun. 343 (2): 591–6. doi:10.1016/j.bbrc.2006.03.015. PMID 16554025.
- Liu Y, Nakahara T, Miyakoshi J, et al. (2007). “Nuclear accumulation and activation of nuclear factor kappaB after split-dose irradiation in LS174T cells”. J. Radiat. Res. 48 (1): 13–20. doi:10.1269/jrr.0615. PMID 17038805.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH